1
|
Qiao Y, Xiong M, Zhang YJ, Tsappidi S, Kan P, Weiss CR, Hui F, Chen SR. Current and future directions in interventional neuro-oncology-are we there yet? J Neurointerv Surg 2024:jnis-2024-021540. [PMID: 38637150 DOI: 10.1136/jnis-2024-021540] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/29/2024] [Accepted: 03/20/2024] [Indexed: 04/20/2024]
Abstract
Advancements in technology and technical expertise increasingly enable neurointerventionalists to deliver safer and more effective endovascular treatments to cancers of the brain, spine, head, and neck. In addition to established neuro-oncological interventions such as pre-surgical tumor embolization and percutaneous ablation, newer modalities focused on direct arterial infusion of chemotherapy, radioisotopes, and radiosensitizers continue to gain traction as complementary treatment options, while stem cell-mediated delivery of theranostic nanoparticles and oncolytic virus are being explored for even greater specificity in targeting cancers across the blood-brain barrier. This article aims to provide an overview of the current state of the art and future directions for the field of interventional neuro-oncology, as well as opportunities and challenges presented by this emerging treatment modality.
Collapse
Affiliation(s)
- Yang Qiao
- Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, Texas, USA
- Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Maggie Xiong
- Department of Diagnostic and Interventional Imaging, The University of Texas Health Science Center at Houston, Houston, Texas, USA
- Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| | - Yi Jonathan Zhang
- Department of Neurointerventional Surgery, The Queen's Health Systems, Honolulu, Hawaii, USA
| | - Samuel Tsappidi
- Department of Neurointerventional Surgery, The Queen's Health Systems, Honolulu, Hawaii, USA
| | - Peter Kan
- Neurosurgery, The University of Texas Medical Branch at Galveston, Galveston, Texas, USA
| | - Clifford R Weiss
- Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, Maryland, USA
- Department of Biomedical Engineering, Johns Hopkins University Whiting School of Engineering, Baltimore, Maryland, USA
| | - Ferdinand Hui
- Department of Neurointerventional Surgery, The Queen's Health Systems, Honolulu, Hawaii, USA
| | - Stephen R Chen
- Department of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
| |
Collapse
|
2
|
Gao X, Cao K, Yang J, Liu L, Gao L. Recent advances in nanotechnology for programmed death ligand 1-targeted cancer theranostics. J Mater Chem B 2024; 12:3191-3208. [PMID: 38497358 DOI: 10.1039/d3tb02787b] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
Programmed cell death ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) checkpoint inhibitor-based immunotherapy has provided a unique and potent weapon against cancer in clinical practice. The likelihood of achieving beneficial effects from PD-L1/PD-1 immune checkpoint blockade (ICB) therapy is clinically assessed by detecting PD-L1 expression through invasive tissue biopsies. However, PD-L1 expression is susceptible to tumor heterogeneity and dynamic response to ICB therapy. Moreover, currently, anti-PD-L1 immunotherapy still faces challenges of the low targeting efficiency of antibody drugs and the risk of immune-associated adverse events. To overcome these issues, advanced nanotechnology has been developed for the purpose of quantitative, non-invasive, and dynamic analyses of PD-L1, and to enhance the efficiency of ICB therapy. In this review, we first introduce the nanoprobe-assisted in vitro/in vivo modalities for the selective and sensitive analysis of PD-L1 during the diagnostic and therapeutic process. On the other hand, the feasibility of fabricating diverse functional nanocarriers as smart delivery systems for precisely targeted delivery of PD-L1 immune checkpoint inhibitors and combined therapies is highlighted. Finally, the current challenges are discussed and future perspectives for PD-L1-targeted cancer theranostics in preclinical research and clinical settings are proposed.
Collapse
Affiliation(s)
- Xinxin Gao
- Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.
| | - Kai Cao
- Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.
| | - Jingru Yang
- Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.
| | - Linhong Liu
- Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.
| | - Liang Gao
- Department of Chemistry, College of Chemistry and Life Science, Beijing University of Technology, Beijing, 100124, China.
| |
Collapse
|
3
|
Vu T, Klippel P, Canning AJ, Ma C, Zhang H, Kasatkina LA, Tang Y, Xia J, Verkhusha VV, Vo-Dinh T, Jing Y, Yao J. On the Importance of Low-Frequency Signals in Functional and Molecular Photoacoustic Computed Tomography. IEEE Trans Med Imaging 2024; 43:771-783. [PMID: 37773898 PMCID: PMC10932611 DOI: 10.1109/tmi.2023.3320668] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/01/2023]
Abstract
In photoacoustic computed tomography (PACT) with short-pulsed laser excitation, wideband acoustic signals are generated in biological tissues with frequencies related to the effective shapes and sizes of the optically absorbing targets. Low-frequency photoacoustic signal components correspond to slowly varying spatial features and are often omitted during imaging due to the limited detection bandwidth of the ultrasound transducer, or during image reconstruction as undesired background that degrades image contrast. Here we demonstrate that low-frequency photoacoustic signals, in fact, contain functional and molecular information, and can be used to enhance structural visibility, improve quantitative accuracy, and reduce spare-sampling artifacts. We provide an in-depth theoretical analysis of low-frequency signals in PACT, and experimentally evaluate their impact on several representative PACT applications, such as mapping temperature in photothermal treatment, measuring blood oxygenation in a hypoxia challenge, and detecting photoswitchable molecular probes in deep organs. Our results strongly suggest that low-frequency signals are important for functional and molecular PACT.
Collapse
|
4
|
Srinivasan ES, Liu Y, Odion RA, Chongsathidkiet P, Wachsmuth LP, Haskell-Mendoza AP, Edwards RM, Canning AJ, Willoughby G, Hinton J, Norton SJ, Lascola CD, Maccarini PF, Mariani CL, Vo-Dinh T, Fecci PE. Gold Nanostars Obviate Limitations to Laser Interstitial Thermal Therapy (LITT) for the Treatment of Intracranial Tumors. Clin Cancer Res 2023; 29:3214-3224. [PMID: 37327318 PMCID: PMC10425731 DOI: 10.1158/1078-0432.ccr-22-1871] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/18/2022] [Revised: 03/27/2023] [Accepted: 06/14/2023] [Indexed: 06/18/2023]
Abstract
PURPOSE Laser interstitial thermal therapy (LITT) is an effective minimally invasive treatment option for intracranial tumors. Our group produced plasmonics-active gold nanostars (GNS) designed to preferentially accumulate within intracranial tumors and amplify the ablative capacity of LITT. EXPERIMENTAL DESIGN The impact of GNS on LITT coverage capacity was tested in ex vivo models using clinical LITT equipment and agarose gel-based phantoms of control and GNS-infused central "tumors." In vivo accumulation of GNS and amplification of ablation were tested in murine intracranial and extracranial tumor models followed by intravenous GNS injection, PET/CT, two-photon photoluminescence, inductively coupled plasma mass spectrometry (ICP-MS), histopathology, and laser ablation. RESULTS Monte Carlo simulations demonstrated the potential of GNS to accelerate and specify thermal distributions. In ex vivo cuboid tumor phantoms, the GNS-infused phantom heated 5.5× faster than the control. In a split-cylinder tumor phantom, the GNS-infused border heated 2× faster and the surrounding area was exposed to 30% lower temperatures, with margin conformation observed in a model of irregular GNS distribution. In vivo, GNS preferentially accumulated within intracranial tumors on PET/CT, two-photon photoluminescence, and ICP-MS at 24 and 72 hours and significantly expedited and increased the maximal temperature achieved in laser ablation compared with control. CONCLUSIONS Our results provide evidence for use of GNS to improve the efficiency and potentially safety of LITT. The in vivo data support selective accumulation within intracranial tumors and amplification of laser ablation, and the GNS-infused phantom experiments demonstrate increased rates of heating, heat contouring to tumor borders, and decreased heating of surrounding regions representing normal structures.
Collapse
Affiliation(s)
- Ethan S. Srinivasan
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
| | - Yang Liu
- Department of Biomedical Engineering, Duke University, Durham, North Carolina
- Department of Chemistry, Duke University, Durham, North Carolina
- Fitzpatrick Institute of Photonics, Duke University, Durham, North Carolina
| | - Ren A. Odion
- Department of Biomedical Engineering, Duke University, Durham, North Carolina
- Fitzpatrick Institute of Photonics, Duke University, Durham, North Carolina
| | - Pakawat Chongsathidkiet
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
- Department of Pathology, Duke University Medical Center, Durham, North Carolina
| | - Lucas P. Wachsmuth
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
| | | | - Ryan M. Edwards
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
| | - Aidan J. Canning
- Department of Biomedical Engineering, Duke University, Durham, North Carolina
- Fitzpatrick Institute of Photonics, Duke University, Durham, North Carolina
| | - Gavin Willoughby
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
- Department of Pathology, Duke University Medical Center, Durham, North Carolina
| | - Joseph Hinton
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
- Department of Pathology, Duke University Medical Center, Durham, North Carolina
| | - Stephen J. Norton
- Department of Biomedical Engineering, Duke University, Durham, North Carolina
- Fitzpatrick Institute of Photonics, Duke University, Durham, North Carolina
| | - Christopher D. Lascola
- Department of Radiology, Duke University Medical Center, Durham, North Carolina
- Department of Neurobiology, Duke University Medical Center, Durham, North Carolina
| | - Paolo F. Maccarini
- Department of Biomedical Engineering, Duke University, Durham, North Carolina
- Fitzpatrick Institute of Photonics, Duke University, Durham, North Carolina
| | - Christopher L. Mariani
- Department of Clinical Sciences, NC State College of Veterinary Medicine, Raleigh, North Carolina
| | - Tuan Vo-Dinh
- Department of Biomedical Engineering, Duke University, Durham, North Carolina
- Department of Chemistry, Duke University, Durham, North Carolina
- Fitzpatrick Institute of Photonics, Duke University, Durham, North Carolina
| | - Peter E. Fecci
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina
- Department of Pathology, Duke University Medical Center, Durham, North Carolina
| |
Collapse
|
5
|
Cai Q, Li X, Xiong H, Fan H, Gao X, Vemireddy V, Margolis R, Li J, Ge X, Giannotta M, Hoyt K, Maher E, Bachoo R, Qin Z. Optical blood-brain-tumor barrier modulation expands therapeutic options for glioblastoma treatment. Nat Commun 2023; 14:4934. [PMID: 37582846 PMCID: PMC10427669 DOI: 10.1038/s41467-023-40579-1] [Citation(s) in RCA: 8] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Accepted: 07/31/2023] [Indexed: 08/17/2023] Open
Abstract
The treatment of glioblastoma has limited clinical progress over the past decade, partly due to the lack of effective drug delivery strategies across the blood-brain-tumor barrier. Moreover, discrepancies between preclinical and clinical outcomes demand a reliable translational platform that can precisely recapitulate the characteristics of human glioblastoma. Here we analyze the intratumoral blood-brain-tumor barrier heterogeneity in human glioblastoma and characterize two genetically engineered models in female mice that recapitulate two important glioma phenotypes, including the diffusely infiltrative tumor margin and angiogenic core. We show that pulsed laser excitation of vascular-targeted gold nanoparticles non-invasively and reversibly modulates the blood-brain-tumor barrier permeability (optoBBTB) and enhances the delivery of paclitaxel in these two models. The treatment reduces the tumor volume by 6 and 2.4-fold and prolongs the survival by 50% and 33%, respectively. Since paclitaxel does not penetrate the blood-brain-tumor barrier and is abandoned for glioblastoma treatment following its failure in early-phase clinical trials, our results raise the possibility of reevaluating a number of potent anticancer drugs by combining them with strategies to increase blood-brain-tumor barrier permeability. Our study reveals that optoBBTB significantly improves therapeutic delivery and has the potential to facilitate future drug evaluation for cancers in the central nervous system.
Collapse
Affiliation(s)
- Qi Cai
- Department of Mechanical Engineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Xiaoqing Li
- Department of Bioengineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Hejian Xiong
- Department of Mechanical Engineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Hanwen Fan
- Department of Mechanical Engineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Xiaofei Gao
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
| | - Vamsidhara Vemireddy
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
- Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
| | - Ryan Margolis
- Department of Bioengineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Junjie Li
- Department of Bioengineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Xiaoqian Ge
- Department of Mechanical Engineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Monica Giannotta
- IFOM ETS - The AIRC Institute of Molecular Oncology, 20139, Milan, Italy
- Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele Scientific Institute, 20132, Milan, Italy
| | - Kenneth Hoyt
- Department of Bioengineering, the University of Texas at Dallas, Richardson, TX, 75080, USA
| | - Elizabeth Maher
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
- Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
| | - Robert Bachoo
- Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
- Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
- Department of Neurology, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
| | - Zhenpeng Qin
- Department of Mechanical Engineering, the University of Texas at Dallas, Richardson, TX, 75080, USA.
- Department of Bioengineering, the University of Texas at Dallas, Richardson, TX, 75080, USA.
- Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA.
- Center for Advanced Pain Studies, the University of Texas at Dallas, Richardson, TX, 75080, USA.
| |
Collapse
|
6
|
Vu T, Klippel P, Canning AJ, Ma C, Zhang H, Kasatkina LA, Tang Y, Xia J, Verkhusha VV, Vo-Dinh T, Jing Y, Yao J. On the importance of low-frequency signals in functional and molecular photoacoustic computed tomography. ArXiv 2023:arXiv:2308.00870v1. [PMID: 37576129 PMCID: PMC10418541] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 08/15/2023]
Abstract
In photoacoustic computed tomography (PACT) with short-pulsed laser excitation, wideband acoustic signals are generated in biological tissues with frequencies related to the effective shapes and sizes of the optically absorbing targets. Low-frequency photoacoustic signal components correspond to slowly varying spatial features and are often omitted during imaging due to the limited detection bandwidth of the ultrasound transducer, or during image reconstruction as undesired background that degrades image contrast. Here we demonstrate that low-frequency photoacoustic signals, in fact, contain functional and molecular information, and can be used to enhance structural visibility, improve quantitative accuracy, and reduce spare-sampling artifacts. We provide an in-depth theoretical analysis of low-frequency signals in PACT, and experimentally evaluate their impact on several representative PACT applications, such as mapping temperature in photothermal treatment, measuring blood oxygenation in a hypoxia challenge, and detecting photoswitchable molecular probes in deep organs. Our results strongly suggest that low-frequency signals are important for functional and molecular PACT.
Collapse
Affiliation(s)
- Tri Vu
- Photoacoustic Imaging Laboratory, Duke University, Durham, NC 27708 USA
| | - Paul Klippel
- Graduate Program in Acoustics, Penn State University, University Park, PA 16802
| | - Aidan J Canning
- Department of Biomedical Engineering, Department of Chemistry, and Fitzpatrick Institute of Photonics, Duke University, Durham, NC 27708
| | - Chenshuo Ma
- Photoacoustic Imaging Laboratory, Duke University, Durham, NC 27708 USA
| | - Huijuan Zhang
- Department of Biomedical Engineering, State University of New York, Buffalo, NY 14260
| | - Ludmila A Kasatkina
- Department of Genetics and Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, NY 10461
| | - Yuqi Tang
- Photoacoustic Imaging Laboratory, Duke University, Durham, NC 27708 USA
| | - Jun Xia
- Department of Biomedical Engineering, State University of New York, Buffalo, NY 14260
| | - Vladislav V Verkhusha
- Department of Genetics and Gruss-Lipper Biophotonics Center, Albert Einstein College of Medicine, Bronx, NY 10461
| | - Tuan Vo-Dinh
- Department of Biomedical Engineering, Department of Chemistry, and Fitzpatrick Institute of Photonics, Duke University, Durham, NC 27708
| | - Yun Jing
- Graduate Program in Acoustics, Penn State University, University Park, PA 16802
| | - Junjie Yao
- Photoacoustic Imaging Laboratory, Duke University, Durham, NC 27708 USA
| |
Collapse
|
7
|
Tarantino S, Caricato AP, Rinaldi R, Capomolla C, De Matteis V. Cancer Treatment Using Different Shapes of Gold-Based Nanomaterials in Combination with Conventional Physical Techniques. Pharmaceutics 2023; 15:pharmaceutics15020500. [PMID: 36839822 PMCID: PMC9968101 DOI: 10.3390/pharmaceutics15020500] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/23/2022] [Revised: 01/23/2023] [Accepted: 01/28/2023] [Indexed: 02/05/2023] Open
Abstract
The conventional methods of cancer treatment and diagnosis, such as radiotherapy, chemotherapy, and computed tomography, have developed a great deal. However, the effectiveness of such methods is limited to the possible failure or collateral effects on the patients. In recent years, nanoscale materials have been studied in the field of medical physics to develop increasingly efficient methods to treat diseases. Gold nanoparticles (AuNPs), thanks to their unique physicochemical and optical properties, were introduced to medicine to promote highly effective treatments. Several studies have confirmed the advantages of AuNPs such as their biocompatibility and the possibility to tune their shapes and sizes or modify their surfaces using different chemical compounds. In this review, the main properties of AuNPs are analyzed, with particular focus on star-shaped AuNPs. In addition, the main methods of tumor treatment and diagnosis involving AuNPs are reviewed.
Collapse
Affiliation(s)
- Simona Tarantino
- Department of Mathematics and Physics “E. De Giorgi”, University of Salento, Via Monteroni, 73100 Lecce, Italy
| | - Anna Paola Caricato
- Department of Mathematics and Physics “E. De Giorgi”, University of Salento, Via Monteroni, 73100 Lecce, Italy
- National Institute of Nuclear Physics (INFN), Section of Lecce, Via Monteroni, 73100 Lecce, Italy
| | - Rosaria Rinaldi
- Department of Mathematics and Physics “E. De Giorgi”, University of Salento, Via Monteroni, 73100 Lecce, Italy
| | - Caterina Capomolla
- “Vito Fazzi” Hospital of Lecce, Oncological Center, Piazza Filippo Muratore 1, 73100 Lecce, Italy
| | - Valeria De Matteis
- Department of Mathematics and Physics “E. De Giorgi”, University of Salento, Via Monteroni, 73100 Lecce, Italy
- Correspondence:
| |
Collapse
|
8
|
Odion RA, Liu Y, Vo-Dinh T. Nanoplasmonics Enabling Cancer Diagnostics and Therapy. Cancers (Basel) 2022; 14:cancers14235737. [PMID: 36497219 PMCID: PMC9739286 DOI: 10.3390/cancers14235737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2022] [Revised: 11/05/2022] [Accepted: 11/19/2022] [Indexed: 11/24/2022] Open
Abstract
In this paper, we highlight several advances our laboratory has developed in the pursuit of cancer diagnostics and therapeutics by integrating plasmonics, photonics, and nanotechnology. We discuss the development and applications of plasmonics-active gold nanostar (GNS), a uniquely shaped nanoparticle with numerous branches that serve to greatly amplify the thermal generation at resonant wavelengths. GNS has also been successfully used in tumor imaging contexts from two-photon fluorescence to surface-enhanced Raman scattering (SERS) sensing and imaging. Finally, GNS has been coupled with immunotherapy applications to serve as an effective adjuvant to immune checkpoint inhibitors. This combination of GNS and immunotherapy, the so called synergistic immuno photo nanotherapy (SYMPHONY), has been shown to be effective at controlling long-lasting cancer immunity and metastatic tumors.
Collapse
Affiliation(s)
- Ren A. Odion
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
| | - Yang Liu
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
- Department of Chemistry, Duke University, Durham, NC 27708, USA
| | - Tuan Vo-Dinh
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
- Department of Chemistry, Duke University, Durham, NC 27708, USA
- Correspondence:
| |
Collapse
|
9
|
Zare I, Yaraki MT, Speranza G, Najafabadi AH, Haghighi AS, Nik AB, Manshian BB, Saraiva C, Soenen SJ, Kogan MJ, Lee JW, Apollo NV, Bernardino L, Araya E, Mayer D, Mao G, Hamblin MR. Gold nanostructures: synthesis, properties, and neurological applications. Chem Soc Rev 2022; 51:2601-2680. [PMID: 35234776 DOI: 10.1039/d1cs01111a] [Citation(s) in RCA: 20] [Impact Index Per Article: 10.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Recent advances in technology are expected to increase our current understanding of neuroscience. Nanotechnology and nanomaterials can alter and control neural functionality in both in vitro and in vivo experimental setups. The intersection between neuroscience and nanoscience may generate long-term neural interfaces adapted at the molecular level. Owing to their intrinsic physicochemical characteristics, gold nanostructures (GNSs) have received much attention in neuroscience, especially for combined diagnostic and therapeutic (theragnostic) purposes. GNSs have been successfully employed to stimulate and monitor neurophysiological signals. Hence, GNSs could provide a promising solution for the regeneration and recovery of neural tissue, novel neuroprotective strategies, and integrated implantable materials. This review covers the broad range of neurological applications of GNS-based materials to improve clinical diagnosis and therapy. Sub-topics include neurotoxicity, targeted delivery of therapeutics to the central nervous system (CNS), neurochemical sensing, neuromodulation, neuroimaging, neurotherapy, tissue engineering, and neural regeneration. It focuses on core concepts of GNSs in neurology, to circumvent the limitations and significant obstacles of innovative approaches in neurobiology and neurochemistry, including theragnostics. We will discuss recent advances in the use of GNSs to overcome current bottlenecks and tackle technical and conceptual challenges.
Collapse
Affiliation(s)
- Iman Zare
- Research and Development Department, Sina Medical Biochemistry Technologies Co. Ltd., Shiraz 7178795844, Iran
| | | | - Giorgio Speranza
- CMM - FBK, v. Sommarive 18, 38123 Trento, Italy.,IFN - CNR, CSMFO Lab., via alla Cascata 56/C Povo, 38123 Trento, Italy.,Department of Industrial Engineering, University of Trento, v. Sommarive 9, 38123 Trento, Italy
| | - Alireza Hassani Najafabadi
- Terasaki Institute for Biomedical Innovation (TIBI), Los Angeles, CA 90064, USA.,Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI, 48109, USA
| | - Alireza Shourangiz Haghighi
- Department of Mechanical Engineering, Shiraz University of Technology, Modarres Boulevard, 13876-71557, Shiraz, Iran
| | - Amirala Bakhshian Nik
- Department of Biomedical Engineering, Florida International University, Miami, FL 33174, USA
| | - Bella B Manshian
- Translational Cell and Tissue Research Unit, Department of Imaging and Pathology, KU Leuven, Herestraat 49, B3000 Leuven, Belgium
| | - Cláudia Saraiva
- Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, 7 Avenue des Hauts-Fourneaux, 4362 Esch-sur-Alzette, Luxembourg.,Health Sciences Research Centre (CICS-UBI), University of Beira Interior, Rua Marques d'Avila e Bolama, 6201-001 Covilha, Portugal
| | - Stefaan J Soenen
- NanoHealth and Optical Imaging Group, Department of Imaging and Pathology, KU Leuven, Herestraat 49, B3000 Leuven, Belgium
| | - Marcelo J Kogan
- Advanced Center for Chronic Diseases (ACCDiS), Facultad de Ciencias Químicas y Farmacéuticas, Departamento de Química Farmacológica y Toxicológica, Universidad de Chile, 8380492 Santiago, Chile
| | - Jee Woong Lee
- Department of Medical Sciences, Clinical Neurophysiology, Uppsala University, Uppsala, SE-751 23, Sweden
| | - Nicholas V Apollo
- Center for Neuroengineering and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.,School of Physics, University of Melbourne, Parkville, Victoria 3010, Australia
| | - Liliana Bernardino
- Health Sciences Research Centre (CICS-UBI), University of Beira Interior, Rua Marques d'Avila e Bolama, 6201-001 Covilha, Portugal
| | - Eyleen Araya
- Departamento de Ciencias Quimicas, Facultad de Ciencias Exactas, Universidad Andres Bello, Av. Republica 275, Santiago, Chile
| | - Dirk Mayer
- Institute of Biological Information Processing, Bioelectronics (IBI-3), Forschungszentrum Jülich GmbH, Germany
| | - Guangzhao Mao
- School of Chemical Engineering, University of New South Wales (UNSW Sydney), Sydney, NSW 2052, Australia
| | - Michael R Hamblin
- Laser Research Center, University of Johannesburg, Doorfontein 2028, South Africa.
| |
Collapse
|
10
|
Abstract
Laser interstitial thermal therapy (LITT) is a minimally invasive treatment for intracranial lesions entailing thermal ablation via a stereotactically placed laser probe. In metastatic disease, it has shown the most promise in the treatment of radiographically progressive lesions after initial stereotactic radiosurgery, whether due to recurrent metastatic disease or radiation necrosis. LITT has been demonstrated to provide clinical benefit in both cases, as discussed in the review below. With its minimal surgical footprint and short recovery period, LITT is further advantaged for patients who are otherwise high-risk surgical candidates or with lesions in difficult to access locations. Exploration of the current data on its use in metastatic disease will allow for a better understanding of the indications, benefits, and future directions of LITT for these patients.
Collapse
Affiliation(s)
| | - Matthew M Grabowski
- Department of Neurosurgery, Cleveland Clinic & Case Comprehensive Cancer Center, Cleveland, Ohio, USA
| | - Brian V Nahed
- Department of Neurosurgery, Massachusetts General Hospital, Boston, Massachusetts, USA
| | - Gene H Barnett
- Department of Neurosurgery, Cleveland Clinic & Case Comprehensive Cancer Center, Cleveland, Ohio, USA
| | - Peter E Fecci
- Department of Neurosurgery, Duke University Medical Center, Durham, North Carolina, USA
| |
Collapse
|
11
|
Abstract
Cancer is among the leading cause of death around the world, causing close to 10 million deaths each year. Significant efforts have been devoted to developing novel technologies that can detect and treat cancer early and effectively to reduce cancer recurrences, treatment costs, and mortality. Gold nanoparticles (GNP) have been given particular attention for its use with photo-induced hyperthermia coupled with novel immunotherapy methods to provide a new platform for highly selective and less invasive cancer treatment. Among the various GNP platforms, gold nanostars (GNS) have a unique star-shaped geometric structure that allows superior light absorption and photothermal heating. This photothermal effect have also been found to amplify the anti-tumor immune response and can be exploited with adjuvant treatments using immune checkpoint inhibitors. This combination treatment known as Synergistic Immuno Photo Nanotherapy (SYMPHONY) has been shown to reverse tumor-mediated immunosuppression and has led to effective and long-lasting immunity against not only primary tumors but also cancer metastasis. This overview highlights the development and applications of GNS-mediated therapy developed in our laboratory for cancer treatment. This paper also presents recent results of experimental studies to illustrate the superior performance of GNS for photothermal treatment applications.
Collapse
Affiliation(s)
- Ren A Odion
- Biomedical Engineering Department, Duke University, Durham, NC 27708 USA
| | - Yang Liu
- Chemistry Department and the Biomedical Engineering Department, Duke University, Durham, NC 27708 USA
| | - Tuan Vo-Dinh
- Biomedical Engineering and Chemistry Department, Duke University, Durham, NC 27708 USA.; Fitzpatrick Institute for Photonics at Duke University
| |
Collapse
|
12
|
Qiu T, Lan Y, Gao W, Zhou M, Liu S, Huang W, Zeng S, Pathak JL, Yang B, Zhang J. Photoacoustic imaging as a highly efficient and precise imaging strategy for the evaluation of brain diseases. Quant Imaging Med Surg 2021; 11:2169-2186. [PMID: 33936997 DOI: 10.21037/qims-20-845] [Citation(s) in RCA: 17] [Impact Index Per Article: 5.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Abstract
Photoacoustic imaging (PAI) is an emerging imaging strategy with a unique combination of rich optical contrasts, high ultrasound spatial resolution, and deep penetration depth without ionizing radiation. Taking advantage of the features mentioned above, PAI has been widely applied to preclinical studies in diverse fields, such as vascular biology, cardiology, neurology, ophthalmology, dermatology, gastroenterology, and oncology. Among various biomedical applications, photoacoustic brain imaging has great importance due to the brain's complex anatomy and the variability of brain disease. In this review, we aimed to introduce a novel and effective imaging modality for diagnosing brain diseases. Firstly, a brief overview of two major types of PAI system was provided. Then, PAI's major preclinical applications in brain diseases were introduced, including early diagnosis of brain tumors, subtle changes in the chemotherapy response, epileptic activity and brain injury, foreign body, and brain plaque. Finally, a perspective of the remaining challenges of PAI was given for future advancements.
Collapse
Affiliation(s)
- Ting Qiu
- Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
| | - Yintao Lan
- Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
| | - Weijian Gao
- Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
| | - Mengyu Zhou
- Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
| | - Shiqi Liu
- Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China
| | - Wenyan Huang
- Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China
| | - Sujuan Zeng
- Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China
| | - Janak L Pathak
- Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China
| | - Bin Yang
- Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China
| | - Jian Zhang
- Department of Biomedical Engineering, School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou, China.,Affiliated Stomatology Hospital of Guangzhou Medical University, Guangzhou Key Laboratory of Basic and Applied Research of Oral Regenerative Medicine, Guangzhou, China
| |
Collapse
|
13
|
Strobbia P, Cupil-Garcia V, Crawford BM, Fales AM, Pfefer TJ, Liu Y, Maiwald M, Sumpf B, Vo-Dinh T. Accurate in vivo tumor detection using plasmonic-enhanced shifted-excitation Raman difference spectroscopy (SERDS). Theranostics 2021; 11:4090-4102. [PMID: 33754050 PMCID: PMC7977455 DOI: 10.7150/thno.53101] [Citation(s) in RCA: 14] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2020] [Accepted: 01/12/2021] [Indexed: 01/15/2023] Open
Abstract
For the majority of cancer patients, surgery is the primary method of treatment. In these cases, accurately removing the entire tumor without harming surrounding tissue is critical; however, due to the lack of intraoperative imaging techniques, surgeons rely on visual and physical inspection to identify tumors. Surface-enhanced Raman scattering (SERS) is emerging as a non-invasive optical alternative for intraoperative tumor identification, with high accuracy and stability. However, Raman detection requires dark rooms to work, which is not consistent with surgical settings. Methods: Herein, we used SERS nanoprobes combined with shifted-excitation Raman difference spectroscopy (SERDS) detection, to accurately detect tumors in xenograft murine model. Results: We demonstrate for the first time the use of SERDS for in vivo tumor detection in a murine model under ambient light conditions. We compare traditional Raman detection with SERDS, showing that our method can improve sensitivity and accuracy for this task. Conclusion: Our results show that this method can be used to improve the accuracy and robustness of in vivo Raman/SERS biomedical application, aiding the process of clinical translation of these technologies.
Collapse
|
14
|
Bastiancich C, Da Silva A, Estève MA. Photothermal Therapy for the Treatment of Glioblastoma: Potential and Preclinical Challenges. Front Oncol 2021; 10:610356. [PMID: 33520720 PMCID: PMC7845694 DOI: 10.3389/fonc.2020.610356] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/25/2020] [Accepted: 12/01/2020] [Indexed: 12/27/2022] Open
Abstract
Glioblastoma (GBM) is a very aggressive primary malignant brain tumor and finding effective therapies is a pharmaceutical challenge and an unmet medical need. Photothermal therapy may be a promising strategy for the treatment of GBM, as it allows the destruction of the tumor using heat as a non-chemical treatment for disease bypassing the GBM heterogeneity limitations, conventional drug resistance mechanisms and side effects on peripheral healthy tissues. However, its development is hampered by the distinctive features of this tumor. Photoabsorbing agents such as nanoparticles need to reach the tumor site at therapeutic concentrations, crossing the blood-brain barrier upon systemic administration. Subsequently, a near infrared light irradiating the head must cross multiple barriers to reach the tumor site without causing any local damage. Its power intensity needs to be within the safety limit and its penetration depth should be sufficient to induce deep and localized hyperthermia and achieve tumor destruction. To properly monitor the therapy, imaging techniques that can accurately measure the increase in temperature within the brain must be used. In this review, we report and discuss recent advances in nanoparticle-mediated plasmonic photothermal therapy for GBM treatment and discuss the preclinical challenges commonly faced by researchers to develop and test such systems.
Collapse
Affiliation(s)
- Chiara Bastiancich
- Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France
| | - Anabela Da Silva
- Aix Marseille Univ, CNRS, Centrale Marseille, Institut Fresnel, Marseille, France
| | - Marie-Anne Estève
- Aix-Marseille Univ, CNRS, INP, Inst Neurophysiopathol, Marseille, France.,APHM, Hôpital de la Timone, Service Pharmacie, Marseille, France
| |
Collapse
|
15
|
Norton SJ, Vo-dinh T. Nanoparticle-Mediated Heating: A Theoretical Study for Photothermal Treatment and Photo Immunotherapy. Bioanalysis 2021. [DOI: 10.1007/978-3-030-78338-9_5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
16
|
Vo-Dinh T. The New Frontier in Medicine at the Convergence of Nanotechnology and Immunotherapy. Bioanalysis 2021. [DOI: 10.1007/978-3-030-78338-9_1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
17
|
Palmer GM, Wang Y, Mansourati A. Intravital Optical Imaging to Monitor Anti-Tumor Immunological Response in Preclinical Models. Bioanalysis 2021. [DOI: 10.1007/978-3-030-78338-9_4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022] Open
|
18
|
Varnamkhasti BS, Jafari S, Taghavi F, Alaei L, Izadi Z, Lotfabadi A, Dehghanian M, Jaymand M, Derakhshankhah H, Saboury AA. Cell-Penetrating Peptides: As a Promising Theranostics Strategy to Circumvent the Blood-Brain Barrier for CNS Diseases. Curr Drug Deliv 2020; 17:375-386. [DOI: 10.2174/1567201817666200415111755] [Citation(s) in RCA: 14] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/01/2019] [Revised: 12/09/2019] [Accepted: 03/18/2020] [Indexed: 12/14/2022]
Abstract
The passage of therapeutic molecules across the Blood-Brain Barrier (BBB) is a profound challenge for the management of the Central Nervous System (CNS)-related diseases. The ineffectual nature of traditional treatments for CNS disorders led to the abundant endeavor of researchers for the design the effective approaches in order to bypass BBB during recent decades. Cell-Penetrating Peptides (CPPs) were found to be one of the promising strategies to manage CNS disorders. CPPs are short peptide sequences with translocation capacity across the biomembrane. With special regard to their two key advantages like superior permeability as well as low cytotoxicity, these peptide sequences represent an appropriate solution to promote therapeutic/theranostic delivery into the CNS. This scenario highlights CPPs with specific emphasis on their applicability as a novel theranostic delivery system into the brain.
Collapse
Affiliation(s)
- Behrang Shiri Varnamkhasti
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical, Sciences, Kermanshah, Iran
| | - Samira Jafari
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical, Sciences, Kermanshah, Iran
| | - Fereshteh Taghavi
- Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
| | - Loghman Alaei
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical, Sciences, Kermanshah, Iran
| | - Zhila Izadi
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical, Sciences, Kermanshah, Iran
| | - Alireza Lotfabadi
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical, Sciences, Kermanshah, Iran
| | - Mojtaba Dehghanian
- Department of Biotechnology, Shahr-e Kord Branch, Islamic Azad University, Shahr-e Kord, Iran
| | - Mehdi Jaymand
- Nano Drug Delivery Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran
| | - Hossein Derakhshankhah
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical, Sciences, Kermanshah, Iran
| | - Ali Akbar Saboury
- Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran
| |
Collapse
|
19
|
Abstract
Gold Nanostars (GNS) have attracted tremendous attention toward themselves owing to their multi-branched structure and unique properties. These state of the art metallic nanoparticles possess intrinsic features like remarkable optical properties and exceptional physiochemical activities. These star-shaped gold nanoparticles can predominantly be utilized in biosensing, photothermal therapy, imaging, surface-enhanced Raman spectroscopy and target drug delivery applications due to their low toxicity and extraordinary optical features. In the current review, recent approaches in the matter of GNS in case of diagnosis, bioimaging and biomedical applications were summarized and reported. In this regard, first an overview about the structure and general properties of GNS were reported and thence detailed information regarding the diagnostic, bioimaging, photothermal therapy, and drug delivery applications of such novel nanomaterials were presented in detail. Summarized information clearly highlighting the superior capability of GNS as potential multi-functional materials for biomedical applications.
Collapse
Affiliation(s)
- Seyyed Mojtaba Mousavi
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan
| | - Maryam Zarei
- Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
| | - Seyyed Alireza Hashemi
- Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore, Singapore
| | - Seeram Ramakrishna
- Department of Mechanical Engineering, Center for Nanofibers and Nanotechnology, National University of Singapore, Singapore, Singapore
| | - Wei-Hung Chiang
- Department of Chemical Engineering, National Taiwan University of Science and Technology, Taipei, Taiwan
| | - Chin Wei Lai
- Nanotechnology & Catalysis Research Centre, University of Malaya, Kuala Lumpur, Malaysia
| | - Ahmad Gholami
- Department of Pharmaceutical Biotechnology, Faculty of Pharmacy and Pharmaceutical research Center, Shiraz University of Medical Science, Shiraz, Iran
| |
Collapse
|
20
|
Langer J, Jimenez de Aberasturi D, Aizpurua J, Alvarez-Puebla RA, Auguié B, Baumberg JJ, Bazan GC, Bell SEJ, Boisen A, Brolo AG, Choo J, Cialla-May D, Deckert V, Fabris L, Faulds K, García de Abajo FJ, Goodacre R, Graham D, Haes AJ, Haynes CL, Huck C, Itoh T, Käll M, Kneipp J, Kotov NA, Kuang H, Le Ru EC, Lee HK, Li JF, Ling XY, Maier SA, Mayerhöfer T, Moskovits M, Murakoshi K, Nam JM, Nie S, Ozaki Y, Pastoriza-Santos I, Perez-Juste J, Popp J, Pucci A, Reich S, Ren B, Schatz GC, Shegai T, Schlücker S, Tay LL, Thomas KG, Tian ZQ, Van Duyne RP, Vo-Dinh T, Wang Y, Willets KA, Xu C, Xu H, Xu Y, Yamamoto YS, Zhao B, Liz-Marzán LM. Present and Future of Surface-Enhanced Raman Scattering. ACS Nano 2020; 14:28-117. [PMID: 31478375 PMCID: PMC6990571 DOI: 10.1021/acsnano.9b04224] [Citation(s) in RCA: 1286] [Impact Index Per Article: 321.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2019] [Accepted: 09/03/2019] [Indexed: 04/14/2023]
Abstract
The discovery of the enhancement of Raman scattering by molecules adsorbed on nanostructured metal surfaces is a landmark in the history of spectroscopic and analytical techniques. Significant experimental and theoretical effort has been directed toward understanding the surface-enhanced Raman scattering (SERS) effect and demonstrating its potential in various types of ultrasensitive sensing applications in a wide variety of fields. In the 45 years since its discovery, SERS has blossomed into a rich area of research and technology, but additional efforts are still needed before it can be routinely used analytically and in commercial products. In this Review, prominent authors from around the world joined together to summarize the state of the art in understanding and using SERS and to predict what can be expected in the near future in terms of research, applications, and technological development. This Review is dedicated to SERS pioneer and our coauthor, the late Prof. Richard Van Duyne, whom we lost during the preparation of this article.
Collapse
Affiliation(s)
- Judith Langer
- CIC
biomaGUNE and CIBER-BBN, Paseo de Miramón 182, Donostia-San Sebastián 20014, Spain
| | | | - Javier Aizpurua
- Materials
Physics Center (CSIC-UPV/EHU), and Donostia
International Physics Center, Paseo Manuel de Lardizabal 5, Donostia-San
Sebastián 20018, Spain
| | - Ramon A. Alvarez-Puebla
- Departamento
de Química Física e Inorgánica and EMaS, Universitat Rovira i Virgili, Tarragona 43007, Spain
- ICREA-Institució
Catalana de Recerca i Estudis Avançats, Passeig Lluís Companys 23, Barcelona 08010, Spain
| | - Baptiste Auguié
- School
of Chemical and Physical Sciences, Victoria
University of Wellington, PO Box 600, Wellington 6140, New Zealand
- The
MacDiarmid
Institute for Advanced Materials and Nanotechnology, PO Box 600, Wellington 6140, New Zealand
- The Dodd-Walls
Centre for Quantum and Photonic Technologies, PO Box 56, Dunedin 9054, New Zealand
| | - Jeremy J. Baumberg
- NanoPhotonics
Centre, Cavendish Laboratory, University
of Cambridge, Cambridge CB3 0HE, United Kingdom
| | - Guillermo C. Bazan
- Department
of Materials and Chemistry and Biochemistry, University of California, Santa
Barbara, California 93106-9510, United States
| | - Steven E. J. Bell
- School
of Chemistry and Chemical Engineering, Queen’s
University of Belfast, Belfast BT9 5AG, United Kingdom
| | - Anja Boisen
- Department
of Micro- and Nanotechnology, The Danish National Research Foundation
and Villum Foundation’s Center for Intelligent Drug Delivery
and Sensing Using Microcontainers and Nanomechanics, Technical University of Denmark, Kongens Lyngby 2800, Denmark
| | - Alexandre G. Brolo
- Department
of Chemistry, University of Victoria, P.O. Box 3065, Victoria, BC V8W 3 V6, Canada
- Center
for Advanced Materials and Related Technologies, University of Victoria, Victoria, BC V8W 2Y2, Canada
| | - Jaebum Choo
- Department
of Chemistry, Chung-Ang University, Seoul 06974, South Korea
| | - Dana Cialla-May
- Leibniz
Institute of Photonic Technology Jena - Member of the research alliance “Leibniz Health Technologies”, Albert-Einstein-Str. 9, Jena 07745, Germany
- Institute
of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller University Jena, Helmholtzweg 4, Jena 07745, Germany
| | - Volker Deckert
- Leibniz
Institute of Photonic Technology Jena - Member of the research alliance “Leibniz Health Technologies”, Albert-Einstein-Str. 9, Jena 07745, Germany
- Institute
of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller University Jena, Helmholtzweg 4, Jena 07745, Germany
| | - Laura Fabris
- Department
of Materials Science and Engineering, Rutgers
University, 607 Taylor Road, Piscataway New Jersey 08854, United States
| | - Karen Faulds
- Department
of Pure and Applied Chemistry, University
of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, United Kingdom
| | - F. Javier García de Abajo
- ICREA-Institució
Catalana de Recerca i Estudis Avançats, Passeig Lluís Companys 23, Barcelona 08010, Spain
- The Barcelona
Institute of Science and Technology, Institut
de Ciencies Fotoniques, Castelldefels (Barcelona) 08860, Spain
| | - Royston Goodacre
- Department
of Biochemistry, Institute of Integrative Biology, University of Liverpool, Biosciences Building, Crown Street, Liverpool L69 7ZB, United Kingdom
| | - Duncan Graham
- Department
of Pure and Applied Chemistry, University
of Strathclyde, Technology and Innovation Centre, 99 George Street, Glasgow G1 1RD, United Kingdom
| | - Amanda J. Haes
- Department
of Chemistry, University of Iowa, Iowa City, Iowa 52242, United States
| | - Christy L. Haynes
- Department
of Chemistry, University of Minnesota, 207 Pleasant Street SE, Minneapolis, Minnesota 55455, United States
| | - Christian Huck
- Kirchhoff
Institute for Physics, University of Heidelberg, Im Neuenheimer Feld 227, Heidelberg 69120, Germany
| | - Tamitake Itoh
- Nano-Bioanalysis
Research Group, Health Research Institute, National Institute of Advanced Industrial Science and Technology, Takamatsu, Kagawa 761-0395, Japan
| | - Mikael Käll
- Department
of Physics, Chalmers University of Technology, Goteborg S412 96, Sweden
| | - Janina Kneipp
- Department
of Chemistry, Humboldt-Universität
zu Berlin, Brook-Taylor-Str. 2, Berlin-Adlershof 12489, Germany
| | - Nicholas A. Kotov
- Department
of Chemical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States
| | - Hua Kuang
- Key Lab
of Synthetic and Biological Colloids, Ministry of Education, International
Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, Jiangsu 214122, China
- State Key
Laboratory of Food Science and Technology, Jiangnan University, JiangSu 214122, China
| | - Eric C. Le Ru
- School
of Chemical and Physical Sciences, Victoria
University of Wellington, PO Box 600, Wellington 6140, New Zealand
- The
MacDiarmid
Institute for Advanced Materials and Nanotechnology, PO Box 600, Wellington 6140, New Zealand
- The Dodd-Walls
Centre for Quantum and Photonic Technologies, PO Box 56, Dunedin 9054, New Zealand
| | - Hiang Kwee Lee
- Division
of Chemistry and Biological Chemistry, School of Physical and Mathematical
Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore
- Department
of Materials Science and Engineering, Stanford
University, Stanford, California 94305, United States
| | - Jian-Feng Li
- State Key
Laboratory of Physical Chemistry of Solid Surfaces, Collaborative
Innovation Center of Chemistry for Energy Materials, MOE Key Laboratory
of Spectrochemical Analysis & Instrumentation, Department of Chemistry,
College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
| | - Xing Yi Ling
- Division
of Chemistry and Biological Chemistry, School of Physical and Mathematical
Sciences, Nanyang Technological University, 21 Nanyang Link, Singapore 637371, Singapore
| | - Stefan A. Maier
- Chair in
Hybrid Nanosystems, Nanoinstitute Munich, Faculty of Physics, Ludwig-Maximilians-Universität München, Munich 80539, Germany
| | - Thomas Mayerhöfer
- Leibniz
Institute of Photonic Technology Jena - Member of the research alliance “Leibniz Health Technologies”, Albert-Einstein-Str. 9, Jena 07745, Germany
- Institute
of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller University Jena, Helmholtzweg 4, Jena 07745, Germany
| | - Martin Moskovits
- Department
of Chemistry & Biochemistry, University
of California Santa Barbara, Santa Barbara, California 93106-9510, United States
| | - Kei Murakoshi
- Department
of Chemistry, Faculty of Science, Hokkaido
University, North 10 West 8, Kita-ku, Sapporo,
Hokkaido 060-0810, Japan
| | - Jwa-Min Nam
- Department
of Chemistry, Seoul National University, Seoul 08826, South Korea
| | - Shuming Nie
- Department of Bioengineering, University of Illinois at Urbana-Champaign, 1406 W. Green Street, Urbana, Illinois 61801, United States
| | - Yukihiro Ozaki
- Department
of Chemistry, School of Science and Technology, Kwansei Gakuin University, Sanda, Hyogo 669-1337, Japan
| | | | - Jorge Perez-Juste
- Departamento
de Química Física and CINBIO, University of Vigo, Vigo 36310, Spain
| | - Juergen Popp
- Leibniz
Institute of Photonic Technology Jena - Member of the research alliance “Leibniz Health Technologies”, Albert-Einstein-Str. 9, Jena 07745, Germany
- Institute
of Physical Chemistry and Abbe Center of Photonics, Friedrich-Schiller University Jena, Helmholtzweg 4, Jena 07745, Germany
| | - Annemarie Pucci
- Kirchhoff
Institute for Physics, University of Heidelberg, Im Neuenheimer Feld 227, Heidelberg 69120, Germany
| | - Stephanie Reich
- Department
of Physics, Freie Universität Berlin, Berlin 14195, Germany
| | - Bin Ren
- State Key
Laboratory of Physical Chemistry of Solid Surfaces, Collaborative
Innovation Center of Chemistry for Energy Materials, MOE Key Laboratory
of Spectrochemical Analysis & Instrumentation, Department of Chemistry,
College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
| | - George C. Schatz
- Department
of Chemistry, Northwestern University, Evanston, Illinois 60208-3113, United States
| | - Timur Shegai
- Department
of Physics, Chalmers University of Technology, Goteborg S412 96, Sweden
| | - Sebastian Schlücker
- Physical
Chemistry I, Department of Chemistry and Center for Nanointegration
Duisburg-Essen, University of Duisburg-Essen, Essen 45141, Germany
| | - Li-Lin Tay
- National
Research Council Canada, Metrology Research
Centre, Ottawa K1A0R6, Canada
| | - K. George Thomas
- School
of Chemistry, Indian Institute of Science
Education and Research Thiruvananthapuram, Vithura Thiruvananthapuram 695551, India
| | - Zhong-Qun Tian
- State Key
Laboratory of Physical Chemistry of Solid Surfaces, Collaborative
Innovation Center of Chemistry for Energy Materials, MOE Key Laboratory
of Spectrochemical Analysis & Instrumentation, Department of Chemistry,
College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, China
| | - Richard P. Van Duyne
- Department
of Chemistry, Northwestern University, Evanston, Illinois 60208-3113, United States
| | - Tuan Vo-Dinh
- Fitzpatrick
Institute for Photonics, Department of Biomedical Engineering, and
Department of Chemistry, Duke University, 101 Science Drive, Box 90281, Durham, North Carolina 27708, United States
| | - Yue Wang
- Department
of Chemistry, College of Sciences, Northeastern
University, Shenyang 110819, China
| | - Katherine A. Willets
- Department
of Chemistry, Temple University, Philadelphia, Pennsylvania 19122, United States
| | - Chuanlai Xu
- Key Lab
of Synthetic and Biological Colloids, Ministry of Education, International
Joint Research Laboratory for Biointerface and Biodetection, Jiangnan University, Wuxi, Jiangsu 214122, China
- State Key
Laboratory of Food Science and Technology, Jiangnan University, JiangSu 214122, China
| | - Hongxing Xu
- School
of Physics and Technology and Institute for Advanced Studies, Wuhan University, Wuhan 430072, China
| | - Yikai Xu
- School
of Chemistry and Chemical Engineering, Queen’s
University of Belfast, Belfast BT9 5AG, United Kingdom
| | - Yuko S. Yamamoto
- School
of Materials Science, Japan Advanced Institute
of Science and Technology, Nomi, Ishikawa 923-1292, Japan
| | - Bing Zhao
- State Key
Laboratory of Supramolecular Structure and Materials, Jilin University, Changchun 130012, China
| | - Luis M. Liz-Marzán
- CIC
biomaGUNE and CIBER-BBN, Paseo de Miramón 182, Donostia-San Sebastián 20014, Spain
- Ikerbasque,
Basque Foundation for Science, Bilbao 48013, Spain
| |
Collapse
|
21
|
Thorat ND, Townely H, Brennan G, Parchur AK, Silien C, Bauer J, Tofail SA. Progress in Remotely Triggered Hybrid Nanostructures for Next-Generation Brain Cancer Theranostics. ACS Biomater Sci Eng 2019; 5:2669-2687. [DOI: 10.1021/acsbiomaterials.8b01173] [Citation(s) in RCA: 26] [Impact Index Per Article: 5.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Affiliation(s)
- Nanasaheb D. Thorat
- Modelling Simulation and Innovative Characterisation (MOSAIC), Department of Physics and Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland
- Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, wybrzeże Stanisława Wyspiańskiego 27, Wrocław 50-370, Poland
| | - Helen Townely
- Nuffield Department of Obstetrics and Gynaecology, Medical Science Division, John Radcliffe Hospital University of Oxford, Oxford OX3 9DU United Kingdom
| | - Grace Brennan
- Modelling Simulation and Innovative Characterisation (MOSAIC), Department of Physics and Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland
| | - Abdul K. Parchur
- Department of Radiology, Medical College of Wisconsin, 9200 W Wisconsin Avenue, Milwaukee, Wisconsin 53226, United States
| | - Christophe Silien
- Modelling Simulation and Innovative Characterisation (MOSAIC), Department of Physics and Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland
| | - Joanna Bauer
- Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, wybrzeże Stanisława Wyspiańskiego 27, Wrocław 50-370, Poland
| | - Syed A.M. Tofail
- Modelling Simulation and Innovative Characterisation (MOSAIC), Department of Physics and Bernal Institute, University of Limerick, Limerick, V94 T9PX, Ireland
| |
Collapse
|
22
|
Vo-Dinh T, Inman BA. What potential does plasmonics-amplified synergistic immuno photothermal nanotherapy have for treatment of cancer? Nanomedicine (Lond) 2018; 13:139-144. [PMID: 29231126 DOI: 10.2217/nnm-2017-0356] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
Affiliation(s)
- Tuan Vo-Dinh
- Department of Biomedical Engineering, Duke University, Durham, NC 27710, USA.,Department of Chemistry, Duke University, Durham, NC 27710, USA.,Fitzpatrick Institute of Photonics, Duke University, Durham, NC 27710, USA
| | - Brant A Inman
- Fitzpatrick Institute of Photonics, Duke University, Durham, NC 27710, USA.,Division of Urology, Duke University, Durham, NC 27710, USA.,Duke Cancer Institute, Duke University, Durham, NC 27710, USA
| |
Collapse
|
23
|
Abstract
Cancer has been a significant threat to human health with more than eight million deaths each year in the world. Therefore, there is a significant need for novel technologies to effectively treat cancer and ultimately reduce cancer recurrences, treatment costs, number of radical cystectomies and mortality. A promising therapeutic platform for cancer is offered by nanoparticle-mediated therapy. This review highlights the development and applications of various nanoparticle platforms for photo-induced hyperthermia and immunotherapy. Taking advantage of gold's high biocompatibility, gold nanoparticles (GNPs) can be injected intravenously and accumulate preferentially in cancer cells due to the enhanced permeability and retention effect. Various gold nanoplatforms including nanospheres, nanoshells, nanorods, nanocages and nanostars have been used for effective photothermal treatment of various cancers. GNPs have also been used in immunotherapies, involving cancer antigen and immune adjuvant delivery as well as combination therapies with photothermal therapy. Among GNPs platforms, gold nanostars (GNS) have great therapeutic potential due to their unique star-shaped geometry that dramatically enhances light absorption and provides high photon-to-heat conversion efficiency due to the plasmonic effect. This photothermal process can be exploited to specifically ablate tumors and, more importantly, to amplify the antitumor immune response following the highly immunogenic thermal death of cancer cells. GNS-mediated photothermal therapy combined with checkpoint immunotherapy has been found to reverse tumor-mediated immunosuppression, thereby leading to the treatment of not only primary tumors but also cancer metastasis, as well as to induce effective long-lasting immunity, in other words, an anticancer ‘vaccine’ effect.
Collapse
Affiliation(s)
- Yang Liu
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
- Department of Chemistry, Duke University, Durham, NC 27708, USA
| | - Bridget M Crawford
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
| | - Tuan Vo-Dinh
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA
- Department of Chemistry, Duke University, Durham, NC 27708, USA
| |
Collapse
|
24
|
Semyachkina-Glushkovskaya O, Chehonin V, Borisova E, Fedosov I, Namykin A, Abdurashitov A, Shirokov A, Khlebtsov B, Lyubun Y, Navolokin N, Ulanova M, Shushunova N, Khorovodov A, Agranovich I, Bodrova A, Sagatova M, Shareef AE, Saranceva E, Iskra T, Dvoryatkina M, Zhinchenko E, Sindeeva O, Tuchin V, Kurths J. Photodynamic opening of the blood-brain barrier and pathways of brain clearing. J Biophotonics 2018; 11:e201700287. [PMID: 29380947 DOI: 10.1002/jbio.201700287] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 10/01/2017] [Revised: 12/22/2017] [Accepted: 01/25/2018] [Indexed: 05/02/2023]
Abstract
A new application of the photodynamic treatment (PDT) is presented for the opening of blood-brain barrier (BBB) and the brain clearing activation that is associated with it, including the use of gold nanoparticles as emerging photosensitizer carriers in PDT. The obtained results clearly demonstrate 2 pathways for the brain clearing: (1) using PDT-opening of BBB and intravenous injection of FITC-dextran we showed a clearance of this tracer via the meningeal lymphatic system in the subdural space; (2) using optical coherence tomography and intraparenchymal injection of gold nanorods, we observed their clearance through the exit gate of cerebral spinal fluid from the brain into the deep cervical lymph node, where the gold nanorods were accumulated. These data contribute to a better understanding of the cerebrovascular effects of PDT and shed light on mechanisms, underlying brain clearing after PDT-related opening of BBB, including clearance from nanoparticles as drug carriers.
Collapse
Affiliation(s)
- Oxana Semyachkina-Glushkovskaya
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | | | - Ekaterina Borisova
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Institute of Electronics, Bulgarian Academy of Sciences, Sofia, Bulgaria
| | - Ivan Fedosov
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Research-Educational Institute of Optics and Biophotonics, Saratov State University (National Research University), Saratov, Russia
| | - Anton Namykin
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Research-Educational Institute of Optics and Biophotonics, Saratov State University (National Research University), Saratov, Russia
| | - Arkady Abdurashitov
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Research-Educational Institute of Optics and Biophotonics, Saratov State University (National Research University), Saratov, Russia
| | - Alexander Shirokov
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (IBPPM RAS), Saratov, Russia
- Saratov State Medical University, Saratov, Russia
| | - Boris Khlebtsov
- Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (IBPPM RAS), Saratov, Russia
| | - Yelena Lyubun
- Institute of Biochemistry and Physiology of Plants and Microorganisms, Russian Academy of Sciences (IBPPM RAS), Saratov, Russia
| | - Nikita Navolokin
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Saratov State Medical University, Saratov, Russia
| | - Mariya Ulanova
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Natalia Shushunova
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Alexander Khorovodov
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Ilana Agranovich
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Anastasia Bodrova
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Madina Sagatova
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Ali Esmat Shareef
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Elena Saranceva
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Tatyana Iskra
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Mariya Dvoryatkina
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Ekaterina Zhinchenko
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Olga Sindeeva
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
| | - Valery Tuchin
- Research-Educational Institute of Optics and Biophotonics, Saratov State University (National Research University), Saratov, Russia
- Tomsk State University (National Research University), Tomsk, Russia
- Institute of Precision Mechanics and Control, Russian Academy of Sciences (IPMC RAS), Saratov, Russia
| | - Jurgen Kurths
- Interdisciplinary Center of Critical Technologies in Medicine, Saratov State University (National Research University), Saratov, Russia
- Physics Department, Humboldt University, Berlin, Germany
- Potsdam Institute for Climate Impact Research, Potsdam, Germany
| |
Collapse
|
25
|
Meola A, Rao J, Chaudhary N, Sharma M, Chang SD. Gold Nanoparticles for Brain Tumor Imaging: A Systematic Review. Front Neurol 2018; 9:328. [PMID: 29867737 PMCID: PMC5960696 DOI: 10.3389/fneur.2018.00328] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/03/2018] [Accepted: 04/25/2018] [Indexed: 11/13/2022] Open
Abstract
Background Demarcation of malignant brain tumor boundaries is critical to achieve complete resection and to improve patient survival. Contrast-enhanced brain magnetic resonance imaging (MRI) is the gold standard for diagnosis and pre-surgical planning, despite limitations of gadolinium (Gd)-based contrast agents to depict tumor margins. Recently, solid metal-based nanoparticles (NPs) have shown potential as diagnostic probes for brain tumors. Gold nanoparticles (GNPs) emerged among those, because of their unique physical and chemical properties and biocompatibility. The aim of the present study is to review the application of GNPs for in vitro and in vivo brain tumor diagnosis. Methods We performed a PubMed search of reports exploring the application of GNPs in the diagnosis of brain tumors in biological models including cells, animals, primates, and humans. The search words were "gold" AND "NP" AND "brain tumor." Two reviewers performed eligibility assessment independently in an unblinded standardized manner. The following data were extracted from each paper: first author, year of publication, animal/cellular model, GNP geometry, GNP size, GNP coating [i.e., polyethylene glycol (PEG) and Gd], blood-brain barrier (BBB) crossing aids, imaging modalities, and therapeutic agents conjugated to the GNPs. Results The PubMed search provided 100 items. A total of 16 studies, published between the 2011 and 2017, were included in our review. No studies on humans were found. Thirteen studies were conducted in vivo on rodent models. The most common shape was a nanosphere (12 studies). The size of GNPs ranged between 20 and 120 nm. In eight studies, the GNPs were covered in PEG. The BBB penetration was increased by surface molecules (nine studies) or by means of external energy sources (in two studies). The most commonly used imaging modalities were MRI (four studies), surface-enhanced Raman scattering (three studies), and fluorescent microscopy (three studies). In two studies, the GNPs were conjugated with therapeutic agents. Conclusion Experimental studies demonstrated that GNPs might be versatile, persistent, and safe contrast agents for multimodality imaging, thus enhancing the tumor edges pre-, intra-, and post-operatively improving microscopic precision. The diagnostic GNPs might also be used for multiple therapeutic approaches, namely as "theranostic" NPs.
Collapse
Affiliation(s)
- Antonio Meola
- Department of Neurosurgery, Stanford University, Stanford, CA, United States
| | - Jianghong Rao
- Department of Radiology, Stanford University, Stanford, CA, United States
| | - Navjot Chaudhary
- Department of Neurosurgery, Stanford University, Stanford, CA, United States
| | - Mayur Sharma
- Department of Neurosurgery, University of Louisville, Louisville, KY, United States
| | - Steven D Chang
- Department of Neurosurgery, Stanford University, Stanford, CA, United States
| |
Collapse
|
26
|
Vo-Dinh T, Liu Y, Crawford BM, Wang HN, Yuan H, Register JK, Khoury CG. Shining Gold Nanostars: From Cancer Diagnostics to Photothermal Treatment and Immunotherapy. J Immunol Sci 2018; 2:1-8. [PMID: 37600154 PMCID: PMC10438859 DOI: 10.29245/2578-3009/2018/1.1104] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 08/22/2023]
Abstract
Cancer has been a significant threat to human health with more than eight million deaths each year in the world. There is an urgent need to develop novel methods to improve cancer management. Biocompatible gold nanostars (GNS) with tip-enhanced electromagnetic and optical properties have been developed and applied for multifunctional cancer diagnostics and therapy (theranostics). The GNS platform can be used for multiple sensing, imaging and treatment modalities, such as surface-enhanced Raman scattering, two-photon photoluminescence, magnetic resonance imaging and computed tomography as well as photothermal therapy and immunotherapy. GNS-mediated photothermal therapy combined with checkpoint immunotherapy has been found to reverse tumor-mediated immunosuppression, leading to the treatment of not only primary tumors but also cancer metastasis as well as inducing effective long-lasting immunity, i.e. an anticancer 'vaccine' effect.
Collapse
Affiliation(s)
- Tuan Vo-Dinh
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| | - Yang Liu
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| | - Bridget M Crawford
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| | - Hsin-Neng Wang
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| | - Hsiangkuo Yuan
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| | - Janna K Register
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| | - Christopher G Khoury
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC 27708-0281, USA
| |
Collapse
|
27
|
Yuan H, Gomez JA, Chien JS, Zhang L, Wilson CM, Li S, Fales AM, Liu Y, Grant GA, Mirotsou M, Dzau VJ, Vo-Dinh T. Tracking mesenchymal stromal cells using an ultra-bright TAT-functionalized plasmonic-active nanoplatform. J Biophotonics 2016; 9:406-413. [PMID: 27095616 PMCID: PMC5645019 DOI: 10.1002/jbio.201500173] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/06/2015] [Revised: 08/11/2015] [Accepted: 08/24/2015] [Indexed: 06/05/2023]
Abstract
High-resolution tracking of stem cells remains a challenging task. An ultra-bright contrast agent with extended intracellular retention is suitable for in vivo high-resolution tracking of stem cells following the implantation. Here, a plasmonic-active nanoplatform was developed for tracking mesenchymal stromal cells (MSCs) in mice. The nanoplatform consisted of TAT peptide-functionalized gold nanostars (TAT-GNS) that emit ultra-bright two-photon photoluminescence capable of tracking MSCs under high-resolution optical imaging. In vitro experiment showed TAT-GNS-labeled MSCs retained a similar differentiability to that of non-labeled MSCs controls. Due to their star shape, TAT-GNS exhibited greater intracellular retention than that of commercial Q-Tracker. In vivo imaging of TAT-GNS-labeled MSCs five days following intra-arterial injections in mice kidneys showed possible MSCs implantation in juxta-glomerular (JG) regions, but non-specifically in glomeruli and afferent arterioles as well. With future design to optimize GNS labeling specificity and clearance, plasmonic-active nanoplatforms may be a useful intracellular tracking tool for stem cell research. An ultra-bright intracellular contrast agent is developed using TAT peptide-functionalized gold nanostars (TAT-GNS). It poses minimal influence on the stem cell differentiability. It exhibits stronger two-photon photoluminescence and superior labeling efficiency than commercial Q-Tracker. Following renal implantation, some TAT-GNS-labeled MSCs permeate blood vessels and migrate to the juxta-glomerular region.
Collapse
Affiliation(s)
- Hsiangkuo Yuan
- Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
| | - Jose A Gomez
- Department of Medicine, Duke University Medical Center and Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA
| | - Jennifer S Chien
- Department of Medicine, Duke University Medical Center and Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA
| | - Lunan Zhang
- Department of Medicine, Duke University Medical Center and Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA
| | - Christy M Wilson
- Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
| | - Shuqin Li
- Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
| | - Andrew M Fales
- Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
| | - Yang Liu
- Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA
- Department of Chemistry, Duke University, NC 27708, USA
| | - Gerald A Grant
- Division of Neurosurgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA
| | - Maria Mirotsou
- Department of Medicine, Duke University Medical Center and Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA
| | - Victor J Dzau
- Department of Medicine, Duke University Medical Center and Mandel Center for Hypertension and Atherosclerosis Research, Durham, NC 27710, USA
| | - Tuan Vo-Dinh
- Department of Biomedical Engineering, Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA.
- Department of Chemistry, Duke University, NC 27708, USA.
| |
Collapse
|
28
|
He L, Dragavon J, Cho S, Mao C, Yildirim A, Ma K, Chattaraj R, Goodwin AP, Park W, Cha JN. Self-assembled gold nanostar–NaYF4:Yb/Er clusters for multimodal imaging, photothermal and photodynamic therapy. J Mater Chem B 2016; 4:4455-4461. [DOI: 10.1039/c6tb00914j] [Citation(s) in RCA: 42] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
A grand challenge for medicine is to develop tools to selectively image and treat diseased cells.
Collapse
Affiliation(s)
- Liangcan He
- Department of Chemical and Biological Engineering
- University of Colorado
- Boulder
- 80303 USA
| | - Joseph Dragavon
- BioFrontiers Advanced Light Microscopy Core
- BioFrontiers Institute
- University of Colorado
- Boulder
- USA
| | - Suehyun Cho
- Department of Electrical
- Computer and Energy Engineering
- University of Colorado
- Boulder
| | - Chenchen Mao
- Department of Electrical
- Computer and Energy Engineering
- University of Colorado
- Boulder
| | - Adem Yildirim
- Department of Chemical and Biological Engineering
- University of Colorado
- Boulder
- 80303 USA
| | - Ke Ma
- Department of Chemical and Biological Engineering
- University of Colorado
- Boulder
- 80303 USA
| | - Rajarshi Chattaraj
- Department of Mechanical Engineering
- University of Colorado
- Boulder
- 80303 USA
| | - Andrew P. Goodwin
- Department of Chemical and Biological Engineering
- University of Colorado
- Boulder
- 80303 USA
- Materials Science and Engineering Program
| | - Wounjhang Park
- Department of Electrical
- Computer and Energy Engineering
- University of Colorado
- Boulder
- Materials Science and Engineering Program
| | - Jennifer N. Cha
- Department of Chemical and Biological Engineering
- University of Colorado
- Boulder
- 80303 USA
- Materials Science and Engineering Program
| |
Collapse
|
29
|
Wang L, Meng D, Hao Y, Hu Y, Niu M, Zheng C, Yanyan Y, Li D, Zhang P, Chang J, Zhang Z, Zhang Y. A gold nanostar based multi-functional tumor-targeting nanoplatform for tumor theranostic applications. J Mater Chem B 2016; 4:5895-5906. [DOI: 10.1039/c6tb01304j] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
A gold nanostar based multi-functional tumor-targeting nanoplatform (DOX/GNSTs–PEG/PEI–FA) for tumor theranostic applications.
Collapse
|
30
|
Wang D, Wu Y, Xia J. Review on photoacoustic imaging of the brain using nanoprobes. Neurophotonics 2016; 3:010901. [PMID: 26740961 PMCID: PMC4699324 DOI: 10.1117/1.nph.3.1.010901] [Citation(s) in RCA: 56] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/12/2015] [Accepted: 11/24/2015] [Indexed: 05/18/2023]
Abstract
Photoacoustic (PA) tomography (PAT) is a hybrid imaging modality that integrates rich optical contrasts with a high-ultrasonic spatial resolution in deep tissue. Among various imaging applications, PA neuroimaging is becoming increasingly important as it nicely complements the limitations of conventional neuroimaging modalities, such as the low-temporal resolution in magnetic resonance imaging and the low depth-to-resolution ratio in optical microscopy/tomography. In addition, the intrinsic hemoglobin contrast PA neuroimaging has also been greatly improved by recent developments in nanoparticles (NPs). For instance, near-infrared absorbing NPs greatly enhanced the vascular contrast in deep-brain PAT; tumor-targeting NPs allowed highly sensitive and highly specific delineation of brain tumors; and multifunctional NPs enabled comprehensive examination of the brain through multimodal imaging. We aim to give an overview of NPs used in PA neuroimaging. Classifications of various NPs used in PAT will be introduced at the beginning, followed by an overview of PA neuroimaging systems, and finally we will discuss major applications of NPs in PA neuroimaging and highlight representative studies.
Collapse
Affiliation(s)
- Depeng Wang
- State University of New York, University at Buffalo, Department of Biomedical Engineering, 208 Bonner Hall, Buffalo, New York 14260, United States
| | - Yun Wu
- State University of New York, University at Buffalo, Department of Biomedical Engineering, 208 Bonner Hall, Buffalo, New York 14260, United States
| | - Jun Xia
- State University of New York, University at Buffalo, Department of Biomedical Engineering, 208 Bonner Hall, Buffalo, New York 14260, United States
| |
Collapse
|
31
|
Abstract
Gold nanoparticle mediated photothermal therapy in future medicine.
Collapse
Affiliation(s)
- Alireza Gharatape
- Department of Medical Nanotechnology
- School of Advanced Medical Science
- Tabriz University of Medical Science
- Tabriz
- Iran
| | - Soodabeh Davaran
- Drug Applied Research Center and Department of Medicinal Chemistry
- Faculty of Pharmacy
- Tabriz University of Medical Science
- Tabriz
- Iran
| | - Roya Salehi
- Research Center for Pharmaceutical Nanotechnology and Department of Medical Nanotechnology
- School of Advanced Medical Science
- Tabriz University of Medical Science
- Tabriz
- Iran
| | - Hamed Hamishehkar
- Drug Applied Research Center
- Tabriz University of Medical Science
- Tabriz
- Iran
| |
Collapse
|
32
|
He L, Mao C, Cho S, Ma K, Xi W, Bowman CN, Park W, Cha JN. Experimental and theoretical photoluminescence studies in nucleic acid assembled gold-upconverting nanoparticle clusters. Nanoscale 2015; 7:17254-17260. [PMID: 26427014 DOI: 10.1039/c5nr05035a] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/05/2023]
Abstract
Combinations of rare earth doped upconverting nanoparticles (UCNPs) and gold nanostructures are sought as nanoscale theranostics due to their ability to convert near infrared (NIR) photons into visible light and heat, respectively. However, because the large NIR absorption cross-section of the gold coupled with their thermo-optical properties can significantly hamper the photoluminescence of UCNPs, methods to optimize the ratio of gold nanostructures to UCNPs must be developed and studied. We demonstrate here nucleic acid assembly methods to conjugate spherical gold nanoparticles (AuNPs) and gold nanostars (AuNSs) to silica-coated UCNPs and probe the effect on photoluminescence. These studies showed that while UCNP fluorescence enhancement was observed from the AuNPs conjugated UCNPs, AuNSs tended to quench fluorescence. However, conjugating lower ratios of AuNSs to UCNPs led to reduced quenching. Simulation studies both confirmed the experimental results and demonstrated that the orientation and distance of the UCNP with respect to the core and arms of the gold nanostructures played a significant role in PL. In addition, the AuNS-UCNP assemblies were able to cause rapid gains in temperature of the surrounding medium enabling their potential use as a photoimaging-photodynamic-photothermal agent.
Collapse
Affiliation(s)
- Liangcan He
- Department of Chemical and Biological Engineering, University of Colorado, Boulder, USA
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Liu Y, Yuan H, Fales AM, Register JK, Vo-Dinh T. Multifunctional gold nanostars for molecular imaging and cancer therapy. Front Chem 2015; 3:51. [PMID: 26322306 PMCID: PMC4533003 DOI: 10.3389/fchem.2015.00051] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2015] [Accepted: 07/30/2015] [Indexed: 12/23/2022] Open
Abstract
Plasmonics-active gold nanoparticles offer excellent potential in molecular imaging and cancer therapy. Among them, gold nanostars (AuNS) exhibit cross-platform flexibility as multimodal contrast agents for macroscopic X-ray computer tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), as well as nanoprobes for photoacoustic tomography (PAT), two-photon photoluminescence (TPL), and surface-enhanced Raman spectroscopy (SERS). Their surfactant-free surface enables versatile functionalization to enhance cancer targeting, and allow triggered drug release. AuNS can also be used as an efficient platform for drug carrying, photothermal therapy, and photodynamic therapy (PDT). This review paper presents the latest progress regarding AuNS as a promising nanoplatform for cancer nanotheranostics. Future research directions with AuNS for biomedical applications will also be discussed.
Collapse
Affiliation(s)
- Yang Liu
- Fitzpatrick Institute for Photonics, Duke University Durham, NC, USA ; Department of Biomedical Engineering, Duke University Durham, NC, USA ; Department of Chemistry, Duke University Durham, NC, USA
| | - Hsiangkuo Yuan
- Fitzpatrick Institute for Photonics, Duke University Durham, NC, USA ; Department of Biomedical Engineering, Duke University Durham, NC, USA
| | - Andrew M Fales
- Fitzpatrick Institute for Photonics, Duke University Durham, NC, USA ; Department of Biomedical Engineering, Duke University Durham, NC, USA
| | - Janna K Register
- Fitzpatrick Institute for Photonics, Duke University Durham, NC, USA ; Department of Biomedical Engineering, Duke University Durham, NC, USA
| | - Tuan Vo-Dinh
- Fitzpatrick Institute for Photonics, Duke University Durham, NC, USA ; Department of Biomedical Engineering, Duke University Durham, NC, USA ; Department of Chemistry, Duke University Durham, NC, USA
| |
Collapse
|
34
|
Liu Y, Ashton JR, Moding EJ, Yuan H, Register JK, Fales AM, Choi J, Whitley MJ, Zhao X, Qi Y, Ma Y, Vaidyanathan G, Zalutsky MR, Kirsch DG, Badea CT, Vo-Dinh T. A Plasmonic Gold Nanostar Theranostic Probe for In Vivo Tumor Imaging and Photothermal Therapy. Theranostics 2015; 5:946-60. [PMID: 26155311 PMCID: PMC4493533 DOI: 10.7150/thno.11974] [Citation(s) in RCA: 178] [Impact Index Per Article: 19.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/24/2015] [Accepted: 04/12/2015] [Indexed: 12/19/2022] Open
Abstract
Nanomedicine has attracted increasing attention in recent years, because it offers great promise to provide personalized diagnostics and therapy with improved treatment efficacy and specificity. In this study, we developed a gold nanostar (GNS) probe for multi-modality theranostics including surface-enhanced Raman scattering (SERS) detection, x-ray computed tomography (CT), two-photon luminescence (TPL) imaging, and photothermal therapy (PTT). We performed radiolabeling, as well as CT and optical imaging, to investigate the GNS probe's biodistribution and intratumoral uptake at both macroscopic and microscopic scales. We also characterized the performance of the GNS nanoprobe for in vitro photothermal heating and in vivo photothermal ablation of primary sarcomas in mice. The results showed that 30-nm GNS have higher tumor uptake, as well as deeper penetration into tumor interstitial space compared to 60-nm GNS. In addition, we found that a higher injection dose of GNS can increase the percentage of tumor uptake. We also demonstrated the GNS probe's superior photothermal conversion efficiency with a highly concentrated heating effect due to a tip-enhanced plasmonic effect. In vivo photothermal therapy with a near-infrared (NIR) laser under the maximum permissible exposure (MPE) led to ablation of aggressive tumors containing GNS, but had no effect in the absence of GNS. This multifunctional GNS probe has the potential to be used for in vivo biosensing, preoperative CT imaging, intraoperative detection with optical methods (SERS and TPL), as well as image-guided photothermal therapy.
Collapse
Affiliation(s)
- Yang Liu
- 1. Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27708, United States
- 2. Department of Biomedical Engineering, Duke University, Durham, NC, 27708, United States
- 3. Department of Chemistry, Duke University, Durham, NC, 27708, United States
| | - Jeffrey R. Ashton
- 2. Department of Biomedical Engineering, Duke University, Durham, NC, 27708, United States
| | - Everett J. Moding
- 4. Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Hsiangkuo Yuan
- 1. Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27708, United States
- 2. Department of Biomedical Engineering, Duke University, Durham, NC, 27708, United States
| | - Janna K. Register
- 1. Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27708, United States
- 2. Department of Biomedical Engineering, Duke University, Durham, NC, 27708, United States
| | - Andrew M. Fales
- 1. Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27708, United States
- 2. Department of Biomedical Engineering, Duke University, Durham, NC, 27708, United States
| | - Jaeyeon Choi
- 5. Department of Radiology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Melodi J. Whitley
- 4. Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Xiaoguang Zhao
- 5. Department of Radiology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Yi Qi
- 6. Center for In Vivo Microscopy, Department of Radiology, Duke University Medical Center, Durham, NC 27710, United States
| | - Yan Ma
- 7. Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Ganesan Vaidyanathan
- 5. Department of Radiology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Michael R. Zalutsky
- 5. Department of Radiology, Duke University Medical Center, Durham, NC, 27710, United States
- 6. Center for In Vivo Microscopy, Department of Radiology, Duke University Medical Center, Durham, NC 27710, United States
| | - David G. Kirsch
- 4. Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC, 27710, United States
- 7. Department of Radiation Oncology, Duke University Medical Center, Durham, NC, 27710, United States
| | - Cristian T. Badea
- 6. Center for In Vivo Microscopy, Department of Radiology, Duke University Medical Center, Durham, NC 27710, United States
| | - Tuan Vo-Dinh
- 1. Fitzpatrick Institute for Photonics, Duke University, Durham, NC, 27708, United States
- 2. Department of Biomedical Engineering, Duke University, Durham, NC, 27708, United States
- 3. Department of Chemistry, Duke University, Durham, NC, 27708, United States
| |
Collapse
|
35
|
Yakunin AN, Avetisyan YA, Tuchin VV. Quantification of laser local hyperthermia induced by gold plasmonic nanoparticles. J Biomed Opt 2015; 20:051030. [PMID: 25629389 DOI: 10.1117/1.jbo.20.5.051030] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/06/2014] [Accepted: 01/06/2015] [Indexed: 06/04/2023]
Abstract
This paper discusses one of the key problems of laser-induced tissue/cell hyperthermia mediated by gold nanoparticles, namely, quantifying and precise prediction of the light exposure to provide a controllable local heating impact on living organisms. The distributions of such parameters as an efficiency factor of absorption, differential and integral absorbing power of a nanoparticle, temperature increment, and Arrhenius damage integral were used to quantify nanoparticle effectiveness in the two-dimensional coordinate space “laser wavelength (λ) × radius of gold nanoparticles (R).” It was found that the fulfillment of required spatial and temporal characteristics of temperature fields in the vicinity of nanoparticle determines the optimal λ and R. As a result, the area in the space (λ × R) with a minimal criticality to alterations of the local hyperthermia may be significantly displaced from the position of the plasmonic resonance. The aspects of generalization of the proposed methodology for the analysis of local hyperthermia using nanoparticles of different shapes (nanoshells, nanorods, nanostars) and short pulse laser radiation are discussed.
Collapse
Affiliation(s)
- Alexander N Yakunin
- Russian Academy of Sciences, Institute of Precise Mechanics and Control, 24 Rabochaya Street, Saratov 410028, RussiabN.G. Chernyshevsky Saratov State University, 83 Astrakhanskaya Street, Saratov 410012, Russia
| | - Yuri A Avetisyan
- Russian Academy of Sciences, Institute of Precise Mechanics and Control, 24 Rabochaya Street, Saratov 410028, RussiabN.G. Chernyshevsky Saratov State University, 83 Astrakhanskaya Street, Saratov 410012, Russia
| | - Valery V Tuchin
- Russian Academy of Sciences, Institute of Precise Mechanics and Control, 24 Rabochaya Street, Saratov 410028, RussiabN.G. Chernyshevsky Saratov State University, 83 Astrakhanskaya Street, Saratov 410012, Russia
| |
Collapse
|
36
|
Liu Y, Yuan H, Kersey FR, Register JK, Parrott MC, Vo-Dinh T. Plasmonic gold nanostars for multi-modality sensing and diagnostics. Sensors (Basel) 2015; 15:3706-20. [PMID: 25664431 PMCID: PMC4367381 DOI: 10.3390/s150203706] [Citation(s) in RCA: 52] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 01/13/2015] [Accepted: 01/30/2015] [Indexed: 12/14/2022]
Abstract
Gold nanostars (AuNSs) are unique systems that can provide a novel multifunctional nanoplatform for molecular sensing and diagnostics. The plasmonic absorption band of AuNSs can be tuned to the near infrared spectral range, often referred to as the "tissue optical window", where light exhibits minimal absorption and deep penetration in tissue. AuNSs have been applied for detecting disease biomarkers and for biomedical imaging using multi-modality methods including surface-enhanced Raman scattering (SERS), two-photon photoluminescence (TPL), magnetic resonance imaging (MRI), positron emission tomography (PET), and X-ray computer tomography (CT) imaging. In this paper, we provide an overview of the recent development of plasmonic AuNSs in our laboratory for biomedical applications and highlight their potential for future translational medicine as a multifunctional nanoplatform.
Collapse
Affiliation(s)
- Yang Liu
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA.
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
- Department of Chemistry, Duke University, Durham, NC 27708, USA.
| | - Hsiangkuo Yuan
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA.
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
| | - Farrell R Kersey
- Department of Radiology & Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, NC 27510, USA.
| | - Janna K Register
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA.
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
| | - Matthew C Parrott
- Department of Radiology & Biomedical Research Imaging Center, University of North Carolina at Chapel Hill, NC 27510, USA.
| | - Tuan Vo-Dinh
- Fitzpatrick Institute for Photonics, Duke University, Durham, NC 27708, USA.
- Department of Biomedical Engineering, Duke University, Durham, NC 27708, USA.
- Department of Chemistry, Duke University, Durham, NC 27708, USA.
| |
Collapse
|
37
|
Vo-Dinh T, Liu Y, Fales AM, Ngo H, Wang HN, Register JK, Yuan H, Norton SJ, Griffin GD. SERS nanosensors and nanoreporters: golden opportunities in biomedical applications. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2014; 7:17-33. [PMID: 25316579 DOI: 10.1002/wnan.1283] [Citation(s) in RCA: 84] [Impact Index Per Article: 8.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/25/2014] [Revised: 06/26/2014] [Accepted: 07/12/2014] [Indexed: 01/30/2023]
Abstract
This article provides an overview of recent developments and applications of surface-enhanced Raman scattering (SERS) nanosensors and nanoreporters in our laboratory for use in biochemical monitoring, medical diagnostics, and therapy. The design and fabrication of different types of plasmonics-active nanostructures are discussed. The SERS nanosensors can be used in various applications including pH sensing, protein detection, and gene diagnostics. For DNA detection the 'Molecular Sentinel' nanoprobe can be used as a homogenous bioassay in solution or on a chip platform. Gold nanostars provide an excellent multi-modality theranostic platform, combining Raman and SERS with two-photon luminescence (TPL) imaging as well as photodynamic therapy (PDT), and photothermal therapy (PTT). Plasmonics-enhanced and optically modulated delivery of nanostars into brain tumor in live animals was demonstrated; photothermal treatment of tumor vasculature may induce inflammasome activation, thus increasing the permeability of the blood brain-tumor barrier. The imaging method using TPL of gold nanostars provides an unprecedented spatial selectivity for enhanced targeted nanostar delivery to cortical tumor tissue. A quintuple-modality nanoreporter based on gold nanostars for SERS, TPL, magnetic resonance imaging (MRI), computed tomography (CT), and PTT has recently been developed. The possibility of combining spectral selectivity and high sensitivity of the SERS process with the inherent molecular specificity of bioreceptor-based nanoprobes provides a unique multiplex and selective diagnostic modality. Several examples of optical detection using SERS in combination with other detection and treatment modalities are discussed to illustrate the usefulness and potential of SERS nanosensors and nanoreporters for medical applications.
Collapse
Affiliation(s)
- Tuan Vo-Dinh
- Fitzpatrick Institute for Photonics, Department of Biomedical Engineering, Department of Chemistry, Duke University, Durham, NC, 27708, USA
| | | | | | | | | | | | | | | | | |
Collapse
|